HIV-1 drug-resistance and drug-dependence

被引：23

作者：

Baldwin, Chris ^{[1
]}

Berkhout, Ben ^{[1
]}

机构：

[1] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,CINIMA, NL-1012 WX Amsterdam, Netherlands

来源：

RETROVIROLOGY | 2007年 / 4卷 / 1期

关键词：

D O I：

10.1186/1742-4690-4-78

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

In this review, we will describe several recent HIV-1 studies in which a drug-dependent virus variant was selected. A common evolutionary route to the drug-dependence phenotype is proposed. First, the selection of a drug-resistance mutation that also affects the function of the targeted viral protein. Second, a compensatory mutation that repairs the protein function, but in the presence of the drug, which becomes an intrinsic part of the mechanism. The clinical relevance of drug-dependent HIV-1 variants is also discussed.

引用

页数：7

共 38 条

[1] Spontaneous mutations in the human immunodeficiency virus type 1 gag gene that affect viral replication in the presence of cyclosporins
Aberham, C
Weber, S
Phares, W
[J]. JOURNAL OF VIROLOGY, 1996, 70 (06) : 3536 - 3544
[2] In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat)
Adamson, Catherine S.
Ablan, Sherimay D.
Boeras, Ioana
Goila-Gaur, Ritu
Soheilian, Ferri
Nagashima, Kunio
Li, Feng
Salzwedel, Karl
Sakalian, Michael
Wild, Carl T.
Freed, Eric O.
[J]. JOURNAL OF VIROLOGY, 2006, 80 (22) : 10957 - 10971
[3] Emergence of a drug-dependent human immunodeficiency virus type 1 variant during therapy with the T20 fusion inhibitor
Baldwin, CE
Sanders, RW
Deng, YQ
Jurriaans, S
Lange, JM
Lu, M
Berkhout, B
[J]. JOURNAL OF VIROLOGY, 2004, 78 (22) : 12428 - 12437
[4] Inhibiting HIV-1 entry with fusion inhibitors
Baldwin, CE
Sanders, RW
Berkhout, B
[J]. CURRENT MEDICINAL CHEMISTRY, 2003, 10 (17) : 1633 - 1642
[5] Second site escape of a T20-dependent HIV-1 variant by a single amino acid change in the CD4 binding region of the envelope glycoprotein
Baldwin, Chris E.
Berkhout, Ben
[J]. RETROVIROLOGY, 2006, 3 (1)
[6] Declining trend in transmission of drug-resistant HIV-1 in Amsterdam
Bezemer, D
Jurriaans, S
Prins, M
van der Hoek, L
Prins, JM
de Wolf, F
Berkhout, B
Coutinho, R
Back, NKT
[J]. AIDS, 2004, 18 (11) : 1571 - 1577
[7] Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A
Braaten, D
Aberham, C
Franke, EK
Yin, L
Phares, W
Luban, J
[J]. JOURNAL OF VIROLOGY, 1996, 70 (08) : 5170 - 5176
[8] Core structure of gp41 from the HIV envelope glycoprotein
Chan, DC
Fass, D
Berger, JM
Kim, PS
[J]. CELL, 1997, 89 (02) : 263 - 273
[9] FUNCTIONAL-ROLE OF THE ZIPPER MOTIF REGION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSMEMBRANE PROTEIN GP41
CHEN, SSL
[J]. JOURNAL OF VIROLOGY, 1994, 68 (03) : 2002 - 2010
[10] HIV-1 adapts to a retrocyclin with cationic amino acid substitutions that reduce fusion efficiency of grp41
Cole, Amy L.
Yang, Otto O.
Warren, Andrew D.
Waring, Alan J.
Lehrer, Robert I.
Cole, Alexander M.
[J]. JOURNAL OF IMMUNOLOGY, 2006, 176 (11) : 6900 - 6905

← 1 2 3 4 →